An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C
- 31 December 1993
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 17 (2), 146-149
- https://doi.org/10.1016/s0168-8278(05)80029-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon-α receptor expression and regulation in chronic hepatitis B virus infectionHepatology, 1991
- High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trialHepatology, 1991
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitisBritish Medical Bulletin, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Interferon antibodies in patients with chronic HBV infection treated with recombinant interferonJournal of Hepatology, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.BMJ, 1989